{"id":13845,"date":"2011-06-08T10:30:00","date_gmt":"2011-06-08T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/pfizer-outsourcing-servizi-trial-a-icon-e-parexel\/"},"modified":"2011-06-08T10:30:00","modified_gmt":"2011-06-08T08:30:00","slug":"pfizer-outsourcing-servizi-trial-a-icon-e-parexel","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/pfizer-outsourcing-servizi-trial-a-icon-e-parexel\/","title":{"rendered":"Pfizer outsourcing trial services to Icon and Parexel"},"content":{"rendered":"<p><font size=\"3\">Pfizer has announced strategic partnerships with Icon and Parexel, which will become strategic service providers for the American drug giant&#039;s clinical trials, for a period of five years starting from June 2011. The new partnership will be fully implemented over a period of 18-24 months. The alliances with Icon and Parexel reflect Pfizer&#039;s commitment to strengthen the performance of its innovative core of products. &quot;We conducted a thorough selection process to find the right partners - says John Hubbard, senior vice president of Development Operations at Pfizer - and chose Icon and Parexel for the strength of their services and their constant commitment to compliance with quality and regulatory dictates&quot;. Pfizer will maintain scientific ownership of clinical development processes and monitor quality standards, safety and regulatory compliance.<\/font><\/p>\n<p align=\"left\"><em>June 8, 2011 \u2013 Pharmakronos<\/em><\/p>\n<p align=\"left\"><img loading=\"lazy\" decoding=\"async\" style=\"width: 193px; height: 129px\" id=\"rg_hi\" class=\"rg_hi\" alt=\"\" width=\"245\" height=\"173\" data-height=\"173\" data-width=\"245\" src=\"http:\/\/t2.gstatic.com\/images?q=tbn:ANd9GcQMNHPzOF4hwaiVuKxTr-1Q5JOVSmOguYJucwKlXKqUQRjOrf8Gvw\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>Pfizer ha annunciato partnership strategiche con Icon e Parexel, che diventano cos&igrave; fornitori strategici di servizi per gli studi clinici del colosso americano del farmaco, per un periodo di cinque anni a partire da giugno 2011. La nuova partnership sar&agrave; pienamente attuata nel corso di un periodo di 18-24 mesi. Le alleanze con Icon e &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-13845","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=13845"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13845\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=13845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=13845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=13845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}